49
Views
82
CrossRef citations to date
0
Altmetric
Original Article

Megakaryoblastic Leukemia and Down's Syndrome: A Review

, &
Pages 211-230 | Received 02 Mar 1987, Accepted 03 Mar 1987, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Aliza Amiel, Moshe D. Fejgin, Meytal Liberman, Yehudit Sharon, Dvora Kidron & Tal Biron-Shental. (2013) Senescence in amniocytes and placentas from trisomy 21 pregnancies. The Journal of Maternal-Fetal & Neonatal Medicine 26:11, pages 1086-1089.
Read now
Richard L. Tower & Logan G. Spector. (2007) The Epidemiology of Childhood Leukemia with a Focus on Birth Weight and Diet. Critical Reviews in Clinical Laboratory Sciences 44:3, pages 203-242.
Read now
F. Mielot, J. Buisine, E. Duchayne, O. Fenneteau, J. Goasguen, A. M. Guitard, M. Maierredelsperger, M. Malet, A. M. Manel, B. Bader-meunier & G. Tchernia. (1998) Myelodysplastic Syndromes In Childhood: Is the FAB Classification Relevant? Report of 81 Children From a French Multicentre Study. Leukemia & Lymphoma 28:5-6, pages 531-540.
Read now
Alvin Zipursky, Hilary Christensen & Etienne De Harven. (1995) Ultrastructural Studies of the Megakaryoblastic Leukemias of Down Syndrome. Leukemia & Lymphoma 18:3-4, pages 341-347.
Read now
J. J. Doyle, P. Thorner, A. Poon, K. Tanswell, S. Kamel Reid & A. Zipursky. (1995) Transient Leukemia Followed by Megakaryoblastic Leukemia in a Child with Mosaic Down Syndrome. Leukemia & Lymphoma 17:3-4, pages 345-350.
Read now
Raul C. Ribeiro, Maria S.P. Oliveira, Diane Fairclough, Craig Hurwitz, Joseph Mirro, Frederick G. Behm, David Head, Maria L.M. Silva, Susana C. Raimondi, William M. Crist & Robert Krance. (1993) Acute Megakaryoblastic Leukemia in Children and Adolescents: A Retrospective Analysis of 24 Cases. Leukemia & Lymphoma 10:4-5, pages 299-306.
Read now
Thomas Lion & Oskar A. Haas. (1993) Acute Megakaryocytic Leukemia with the t(1;22)(p13;q13. Leukemia & Lymphoma 11:1-2, pages 15-20.
Read now
. (1993) Test and Teach Number Seventy Part 2. Pathology 25:2, pages 207-208.
Read now
Hiroki Kurahashi, Junichi Hara, Keiko Yumura-Yag, Akio Tawa & Keisei Kawa-Ha. (1992) Transient Abnormal Myelopoiesis in Down's Syndrome. Leukemia & Lymphoma 8:6, pages 465-475.
Read now
Alvin Zipursky, Annete Poon & John Doyle. (1992) Leukemia in Down Syndrome: A Review. Pediatric Hematology and Oncology 9:2, pages 139-149.
Read now
Barbara Bain. (1991) Down's Syndrome—Transient Abnormal Myelopoiesis and Acute Leukaemia. Leukemia & Lymphoma 3:5-6, pages 309-317.
Read now
Eduardo Lobato-mendizabal, Antonio Marín-lopez, Guillermo López-de-la-cruz, Manuel Presno-bernal & Guillermo J. Ruiz-Argüelles. (1990) Congenital Acute Megakaryoblastic Leukaemia in Down's Syndrome. Leukemia & Lymphoma 2:1-2, pages 137-139.
Read now

Articles from other publishers (70)

R. N. Suprun, Yu. V. Rumyantseva, O. I. Bydanov, L. I. Zharikova, S. N. Lagoiko, V. V. Lebedev, K. L. Kondratchik, E. A. Druy, E. G. Mansurova, T. V. Asekretova, O. E. Murashkina, O. V. Aleynikova, L. G. Fechina, G. V. Bykova, N. I. Ponomareva, N. V. Myakova, A. M. Popov, Yu. V. Olshanskaya, A. N. Kazakova, D. V. Litvinov, G. A. Novichkova & A. I. Karachunskiy. (2022) Acute lymphoblastic leukemia in children with Down syndrome: comparative analysis of treatment results according to ALL-MB 2008 and ALL-MB 2015 protocols. Russian Journal of Pediatric Hematology and Oncology 9:3, pages 12-31.
Crossref
Kunming Qi, Xueting Hu, Xiangru Yu, Hai Cheng, Chunqing Wang, Shujin Wang, Ying Wang, Yanjie Li, Jiang Cao, Bin Pan, Qingyun Wu, Jianlin Qiao, Lingyu Zeng, Zhenyu Li, Kailin Xu & Chunling Fu. (2022) Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia. Leukemia Research 120, pages 106920.
Crossref
Avanti Gupte, Eman T. Al-Antary, Holly Edwards, Yaddanapudi Ravindranath, Yubin Ge & Jeffrey W. Taub. (2022) The paradox of Myeloid Leukemia associated with Down syndrome. Biochemical Pharmacology 201, pages 115046.
Crossref
Emily C. Marlow, Jonathan Ducore, Marilyn L. Kwan, Stephanie Y. Cheng, Erin J.A. Bowles, Robert T. Greenlee, Jason D. Pole, Alanna Kulchak Rahm, Natasha K. Stout, Sheila Weinmann, Rebecca Smith-Bindman & Diana L. Miglioretti. (2021) Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome. The Journal of Pediatrics 234, pages 172-180.e3.
Crossref
Tiffany Kaul, Craig Lotterman & Rajasekharan Warrier. (2019) Adolescent With Down Syndrome Who Refuses to Walk. Clinical Pediatrics 58:11-12, pages 1357-1359.
Crossref
Andrew W. Hahn, Bojia Li, Philippe Prouet, Smith Giri, Ranjan Pathak & Mike G. Martin. (2016) Acute megakaryocytic leukemia: What have we learned. Blood Reviews 30:1, pages 49-53.
Crossref
Jana Schweitzer, Martin Zimmermann, Mareike Rasche, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt & Jan-Henning Klusmann. (2015) Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Annals of Hematology 94:8, pages 1327-1336.
Crossref
Hideki Muramatsu, Hirotoshi Sakaguchi, Takashi Taga, Ken Tabuchi, Souichi Adachi, Masami Inoue, Toshiyuki Kitoh, Aiko Suminoe, Hiromasa Yabe, Eichi Azuma, Yoko Shioda, Atsushi Ogawa, Akitoshi Kinoshita, Hisato Kigasawa, Yuko Osugi, Kazutoshi Koike, Keisei Kawa, Koji Kato, Yoshiko Atsuta & Kazuko Kudo. (2014) Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome. Pediatric Blood & Cancer 61:5, pages 925-927.
Crossref
Diane S. Krause & John D. Crispino. (2013) Molecular Pathways: Induction of Polyploidy as a Novel Differentiation Therapy for Leukemia. Clinical Cancer Research 19:22, pages 6084-6088.
Crossref
Andrew J. Woo, Karen Wieland, Hui Huang, Thomas E. Akie, Taylor Piers, Jonghwan Kim & Alan B. Cantor. (2013) Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation. Journal of Clinical Investigation 123:8, pages 3292-3304.
Crossref
Alan S. Gamis & Franklin O. Smith. (2012) Transient myeloproliferative disorder in children with D own syndrome: clarity to this enigmatic disorder . British Journal of Haematology 159:3, pages 277-287.
Crossref
Susanne Haemmerling, Wolfgang Behnisch, Tobias Doerks, Jan O. Korbel, Peer Bork, Ute Moog, Sabine Hentze, Ute Grasshoff, Michael Bonin, Olaf Rieß, Johannes W. G. Janssen, Anna Jauch, Claus R. Bartram, Dirk Reinhardt, Karin A. Koch, Obul R. Bandapalli & Andreas E. Kulozik. (2012) A 15q24 microdeletion in transient myeloproliferative disease ( TMD ) and acute megakaryoblastic leukaemia ( AMKL ) implicates PML and SUMO 3 in the leukaemogenesis of TMD / AMKL . British Journal of Haematology 157:2, pages 180-187.
Crossref
Alan S. GamisTodd A. AlonzoRobert B. GerbingJoanne M. HildenApril D. SorrellMukta SharmaThomas W. LoewRobert J. ArceciDorothy BarnardJohn DoyleGita MasseyJohn Perentesis, Yaddanapudi Ravindranath, Jeffrey Taub & Franklin O. Smith. (2011) Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood 118:26, pages 6752-6759.
Crossref
Huiyuan Li, Haifeng Zhao, Donghai Wang & Renchi Yang. (2011) microRNA regulation in megakaryocytopoiesis. British Journal of Haematology 155:3, pages 298-307.
Crossref
Yi Xiao, Jia Wei, Jin-huan Xu, Jian-feng Zhou & Yi-cheng Zhang. (2011) Mosaic trisomy 21 and trisomy 14 as acquired cytogenetic abnormalities without GATA1 mutation in a pediatric non-down syndrome acute megakaryoblastic leukemia. Chinese Journal of Cancer Research 23:3, pages 239-241.
Crossref
R. Sukenik-Halevy, T. Biron-Shental, R. Sharony, M.D. Fejgin & A. Amiel. (2011) Telomeres in Trisomy 21 Amniocytes. Cytogenetic and Genome Research 135:1, pages 12-18.
Crossref
Stefano Comazzi, Maria E. Gelain, Ugo Bonfanti & Paola Roccabianca. (2010) Acute Megakaryoblastic Leukemia in Dogs: A Report of Three Cases and Review of the Literature. Journal of the American Animal Hospital Association 46:5, pages 327-335.
Crossref
Julie Tandonnet, Jacqueline Clavel, André Baruchel, Fabienne Nacka & Yves Pérel. (2010) Myeloid leukaemia in children with down syndrome: Report of the registry‐based French experience between 1990 and 2003. Pediatric Blood & Cancer 54:7, pages 927-933.
Crossref
Indranil Ghosh, Lalit Kumar, Rachna Seth & Vasantha Thavraj. (2009) Sustained Remission Achieved With ATRA and Chemotherapy in Second Relapse of Acute Promyelocytic Leukemia in Down Syndrome. Journal of Pediatric Hematology/Oncology 31:8, pages 539-540.
Crossref
Hany Ariffin, Jaime Castillo Garcia, Siti Sarah Daud, Kamariah Ibrahim, Nik Aizah, Gek‐Bee Ong, Lee‐Ai Chong & Zulqarnain Mohamad. (2009) GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis . Pediatric Blood & Cancer 53:1, pages 108-111.
Crossref
Oren Ben-Ami, Niv Pencovich, Joseph Lotem, Ditsa Levanon & Yoram Groner. (2009) A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proceedings of the National Academy of Sciences 106:1, pages 238-243.
Crossref
Jennifer J. Clark, Jason N. Berman & A. Thomas Look. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood 331 402 .
Amy M. Linabery, Cindy K. Blair, Alan S. Gamis, Andrew F. Olshan, Nyla A. Heerema & Julie A. Ross. (2008) Congenital Abnormalities and Acute Leukemia among Children with Down Syndrome: A Children's Oncology Group Study. Cancer Epidemiology, Biomarkers & Prevention 17:10, pages 2572-2577.
Crossref
Asahito Hama, Hiroshi Yagasaki, Yoshiyuki Takahashi, Nobuhiro Nishio, Hideki Muramatsu, Nao Yoshida, Makito Tanaka, Hirokazu Hidaka, Nobuhiro Watanabe, Ayami Yoshimi, Kimikazu Matsumoto, Kazuko Kudo, Koji Kato, Keizo Horibe & Seiji Kojima. (2008) Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome. British Journal of Haematology 140:5, pages 552-561.
Crossref
Erik ForestierShai IzraeliBerna BeverlooOskar HaasAndrea PessionKyra MichalováBatia StarkChristine J. HarrisonAndrea Teigler-Schlegel & Bertil Johansson. (2008) Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood 111:3, pages 1575-1583.
Crossref
Kazuko KudoSeiji KojimaKen TabuchiHiromasa YabeAkio TawaMasue ImaizumiRyoji HanadaKazuko HamamotoRyoji KobayashiAkira MorimotoHideki NakayamaMasahiro TsuchidaKeizo HoribeHisato KigasawaIchiro Tsukimoto. (2007) Prospective Study of a Pirarubicin, Intermediate-Dose Cytarabine, and Etoposide Regimen in Children With Down Syndrome and Acute Myeloid Leukemia: The Japanese Childhood AML Cooperative Study Group. Journal of Clinical Oncology 25:34, pages 5442-5447.
Crossref
Johann K. Hitzler. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatric Blood & Cancer 49:S7, pages 1066-1069.
Crossref
Anupama Rao, Robert K. Hills, Charles Stiller, Brenda E. Gibson, Siebold S.N. Graaf, Ian M. Hann, Aengus O'Marcaigh, Keith Wheatley & David K.H. Webb. (2006) Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. British Journal of Haematology 132:5, pages 576-583.
Crossref
Fred G. Behm. 2010. Childhood Leukemias. Childhood Leukemias 150 209 .
Angela J Villar & Charles J Epstein. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Errol C. Friedberg, Graham C. Walker, Wolfram Siede, Richard D. Wood, Roger A. Schultz & Tom Ellenberger. 2005. DNA Repair and Mutagenesis. DNA Repair and Mutagenesis 1001 1047 .
U Creutzig, D Reinhardt, S Diekamp, M Dworzak, J Stary & M Zimmermann. (2005) AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia 19:8, pages 1355-1360.
Crossref
E. Roman, J. Simpson, P. Ansell, T. Lightfoot, C. Mitchell & T.O.B. Eden. (2005) Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. European Journal of Cancer 41:5, pages 749-759.
Crossref
Jouni Vesa, Ying Brown, Danielle Greenfield & Julie R. Korenberg. (2005) Molecular and cellular characterization of the Down syndrome critical region protein 2. Biochemical and Biophysical Research Communications 328:1, pages 235-242.
Crossref
Yaddanapudi Ravindranath. (2005) Down syndrome and leukemia: New insights into the epidemiology, pathogenesis, and treatment. Pediatric Blood & Cancer 44:1, pages 1-7.
Crossref
Julie A. Ross, Logan G. Spector, Leslie L. Robison & Andrew F. Olshan. (2005) Epidemiology of leukemia in children with Down syndrome. Pediatric Blood & Cancer 44:1, pages 8-12.
Crossref
Shai Izraeli. (2004) Leukaemia - a developmental perspective. British Journal of Haematology 126:1, pages 3-10.
Crossref
Lila PenchanskyLila Penchansky. 2004. Pediatric Bone Marrow. Pediatric Bone Marrow 133 149 .
Alan S. GamisWilliam G. WoodsTodd A. AlonzoAllen BuxtonBeverly LangeDorothy R. BarnardStuart GoldFranklin O. Smith. (2003) Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891. Journal of Clinical Oncology 21:18, pages 3415-3422.
Crossref
Chetana Bakshi, Pratibha Amare (Kadam)Dhiraj Abhyankar, Chanda Baisane, Shripad Banavali & Suresh Advani. (2003) Chromosomal rearrangement in Down syndrome with acute myeloid leukemia. The Indian Journal of Pediatrics 70:9, pages 755-758.
Crossref
O Hrušák & A Porwit-MacDonald. (2002) Antigen expression patterns reflecting genotype of acute leukemias. Leukemia 16:7, pages 1233-1258.
Crossref
Shawn E. Holt, Elizabeth J. Brown & Alvin Zipursky. (2002) Telomerase and the Benign and Malignant Megakaryoblastic Leukemias of Down Syndrome. Journal of Pediatric Hematology/Oncology 24:1, pages 14-17.
Crossref
Fawaz Al-Kasim, John J. Doyle, Gita V. Massey, Howard J. Weinstein & Alvin Zipursky. (2002) Incidence and Treatment of Potentially Lethal Diseases in Transient Leukemia of Down Syndrome: Pediatric Oncology Group Study. Journal of Pediatric Hematology/Oncology 24:1, pages 9-13.
Crossref
Alan S. Gamis & Joanne M. Hilden. (2002) Transient Myeloproliferative Disorder, a Disorder With Too Few Data and Many Unanswered Questions: Does It Contain an Important Piece of the Puzzle to Understanding Hematopoiesis and Acute Myelogenous Leukemia?. Journal of Pediatric Hematology/Oncology 24:1, pages 2-5.
Crossref
Peter B. Langmuir, Richard Aplenc & Beverly J. Lange. (2001) Acute myeloid leukaemia in children. Best Practice & Research Clinical Haematology 14:1, pages 77-93.
Crossref
Beverly Lange. (2001) The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome. British Journal of Haematology 110:3, pages 512-524.
Crossref
Hiroaki Ohnishi, Tomohiko Taki, Ken Tabuchi, Miyuki Kobayashi, Fumio Bessho & Yasuhide Hayashi. (2000) Down's syndrome with myelodysplastic syndrome showing t(7;11)(p13;p14). American Journal of Hematology 65:1, pages 62-65.
Crossref
David Malkin, Elizabeth J Brown & Alvin Zipursky. (2000) The Role of p53 in Megakaryocyte Differentiation and the Megakaryocytic Leukemias of Down Syndrome. Cancer Genetics and Cytogenetics 116:1, pages 1-5.
Crossref
Dorothée Duflos-Delaplace, Jean-Luc Laı̈, Brigitte Nelken, Franck Genevieve, Anne-Sophie Defachelles & Marc Zandecki. (1999) Transient Leukemoid Disorder in a Newborn with Down Syndrome Followed 19 Months Later by an Acute Myeloid Leukemia. Cancer Genetics and Cytogenetics 113:2, pages 166-171.
Crossref
Carolyn A. Felix & Beverly J. Lange. (1999) Leukemia in Infants. The Oncologist 4:3, pages 225-240.
Crossref
Fred G. Behm. (1999) Diagnosis of Childhood Acute Myeloid Leukemia. Clinics in Laboratory Medicine 19:1, pages 187-238.
Crossref
Gowthami Arepally, Timothy R. Rebbeck, Woojoo Song, Gary Gilliland, John M. Maris & Mortimer Poncz. (1998) Evidence for Genetic Homogeneity in a Familial Platelet Disorder With Predisposition to Acute Myelogenous Leukemia (FPD/AML). Blood 92:7, pages 2600-2602.
Crossref
Simona Cavani, Chiara Perfumo, Alessandra Argusti, Mauro Pierluigi, Lucia Perroni, Kjeld Schmiegelow, Michael B. Petersen, Finbarr E. Cotter, Paolo Strigini, Franca Dagna‐Bricarelli & Dean NižetiĆ. (2002) Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q. British Journal of Haematology 103:1, pages 213-216.
Crossref
Pedro Zubizarreta, Mar??a S Felice, Elizabeth Alfaro, Lidia Fraquelli, Sandra Casak, Rub?n Quinteros, Ana Cygler, Marta Gallego, Laura E P?rez & Federico Sackmann-Muriel. (1998) Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy. Leukemia Research 22:5, pages 465-472.
Crossref
Andrew M. Fisher. (1997) Are trisomy 21 fetuses subject to a myoproliferation which is manifest in the maternal blood?. Prenatal Diagnosis 17:9, pages 885-886.
Crossref
U. Creutzig, J. Ritter, C. Niemeyer, B. Stollmann-Gibbels, M. Zimmermann, I. Reinisch & J. Harbott. 1997. Acute Leukemias VI. Acute Leukemias VI 754 760 .
D. LEVANON, Y. BERNSTEIN, V. NEGREANU, M.C. GHOZI, I. BAR-AM, R. ALOYA, D. GOLDENBERG, J. LOTEM & Y. GRONER. (1996) A Large Variety of Alternatively Spliced and Differentially Expressed mRNAs Are Encoded by the Human Acute Myeloid Leukemia Gene AML1. DNA and Cell Biology 15:3, pages 175-185.
Crossref
Pedro Zubizarreta, Federico Sackmann Muriel & María Angélica Fernández Barbieri. (2006) Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: Report of two cases with trisomy 21 mosaicism. Medical and Pediatric Oncology 25:1, pages 60-64.
Crossref
Robert W. Miller, John L Young & Biljana Novakovic. (1995) Childhood cancer. Cancer 75:S1, pages 395-405.
Crossref
A.M. Fisher, A. E. Cockwell, P. A. Jacobs & H. F. Parry. (2009) Incidence of circulating cells positive for GpIb and GpIIIa in infants with Down's syndrome. European Journal of Haematology 53:1, pages 46-48.
Crossref
A. GOLETA‐DY, L. DALLA POZZA, P. J. SHAW & M. M. STEVENS. (2008) Acute myeloid leukaemia in patients with trisomy 21 (Down syndrome) treated by bone marrow transplantation. Journal of Paediatrics and Child Health 30:3, pages 275-277.
Crossref
A. Zipursky, P. Thorner, E. De Harven, H. Christensen & J. Doyle. (1994) Myelodysplasia and acute megakaryoblastic leukemia in down's syndrome. Leukemia Research 18:3, pages 163-171.
Crossref
Guohui Lu, Arnold J. Altman & Peter A. Benn. (1993) Review of the cytogenetic changes in acute megakaryoblastic leukemia: One disease or several?. Cancer Genetics and Cytogenetics 67:2, pages 81-89.
Crossref
Sofie H. Slørdahl, Erlend B. Smeland, Harald Holte, Morten Grønn, Sverre O. Lie & Martin Seip. (2006) Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”). Medical and Pediatric Oncology 21:4, pages 254-258.
Crossref
Briana J. Lorber, Sallie B. Freeman, Terry Hassold, Abdel H. Ragab, Roger A. Vega, Annette E. Cockwell, Patricia A. Jacobs, Martin Radford, John Doyle, Ian D. Dubé & Alvin Zipursky. (2006) Characterization and molecular analysis of nondisjunction in 18 cases of trisomy 21 and leukemia. Genes, Chromosomes and Cancer 4:3, pages 222-227.
Crossref
Lyndal Kearney, Paul C. Watkins, Bryan D. Young & Nicoletta Sacchi. (1991) DNA sequences of chromosome 21-specific YAC detect the t(8;21) breakpoint of acute myelogenous leukemia. Cancer Genetics and Cytogenetics 57:1, pages 109-119.
Crossref
Nancy Bunin, Peter C. Nowell, Jean Belasco, Narayan Shah, Michael Willoughby, Philip A. Farber & Beverly Lange. (1991) Chromosome 7 abnormalities in children with Down syndrome and preleukemia. Cancer Genetics and Cytogenetics 54:1, pages 119-126.
Crossref
Amar Dave, J. Ramet, B. Hauser, E. Schmedding, Giovanni Amendola, Lucia Amato, Giuseppe Cirillo, Giuseppe Dante, Francis J. DiMario, Clair M. Chee & Peter H. Berman. (2016) Letters to the Editor. Clinical Pediatrics 29:8, pages 485-487.
Crossref
Lila Penchansky, Suzanne R. Taylor & John R. Krause. (1989) Three infants with acute megakaryoblastic leukemia simulating metastatic tumor. Cancer 64:6, pages 1366-1371.
Crossref
Beatrice C. Lampkin, Beverly Lange, Irwin Bernstein, William Woods, Lorrie Odom, Robert Wells, Frederick Ruymann, Stephen Feig, Linda Miller, Ronald Chard, Denis Benjamin, Jonathan Buckley, Tae Kim & Denman Hammond. (1988) Biologic Characteristics and Treatment of Acute Nonlymphocytic Leukemia in Children: Report of the ANLL Strategy Group of the Childrens Cancer Study Group. Pediatric Clinics of North America 35:4, pages 743-764.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.